Rishi Bedi

CEO
Y-Trap

​​​
Rishi Bedi is CEO of Y-Trap, a biotechnology startup developing novel fusion proteins for cancer immunotherapy. His experience spans universal vaccine design (Centivax), machine learning phenotyping of brain organoids (Herophilus), and algorithms for antibody repertoire analysis (Distributed Bio). He trained in artificial intelligence and computational biology at Stanford, where he worked on machine learning methods for structural biology.